poison centers have shown an increase in medical issues related to compounded GLP-1 drugs, including overdoses and dosing errors, and the FDA identified instances of improper storage and inadequate refrigeration in shipments of these drugs, potentially compromising drug quality
This very large, diverse group of compounds can also be referred to as synthetic cannabinoid receptor agonists
10.1172/JCI45586 173 PablaN.DongZ
Thus, this provides the rationale for the observed larger therapeutic window for cAC10-vc-MMAF than the corresponding cAC10-vc-MMAE (17)
August 1, 2025: Wegovy Vision Loss Group Lawsuit Under Consideration in New Jersey The New Jersey Supreme Court is considering a petition to create a multicounty group claim for people who have filed New Jersey vision loss cases against Wegovys maker, Novo Nordisk
Ipamorelin C38H49N9O5 Molecular Weight Tesamorelin 5135.86 g/mol